#patient-access

#patient-access

THE TOPLINE The FDA has stated it plans to remove all natural desiccated thyroid (NDT) products from the market within 12 months, impacting millions who rely on NDT for effective thyroid hormone replacement. Despite decades of safe use and minimal adverse event reports, the FDA demands costly approval processes that NDT manufacturers cannot realistically meet. This enforcement is part of a broader and long-term pattern of restricting access to natural and compounded medicines, limiting patient choice, and consolidating pharmaceutical industry control.

The company is tackling one of healthcare's most persistent problems: access. Known as the "front door" of healthcare, communication and scheduling systems often determine whether patients can actually secure timely care. Across the U.S., as many as 42% of patient calls and texts go unanswered during peak hours, largely due to staffing shortages and overburdened call centers. This leads to delays in care, missed appointments, and revenue loss for practices.

"Under a new law that went into effect July 1, doctors in Florida can administer unapproved stem-cell therapies for wound care, pain management, or orthopedic purposes."

The new law significantly broadens medical cannabis access in Texas by introducing an inclusive list of qualifying conditions, delivering critical wellness alternatives to patients.

It's shocking that there is so much miscommunication regarding parking for employees who have been hired expecting to park at their workplace.